Front Row Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-106
| Closed | -$12K | – | 973 |
|
2022
Q4 | $12K | Buy |
106
+11
| +12% | +$1.25K | 0.01% | 471 |
|
2022
Q3 | $6K | Sell |
95
-7
| -7% | -$442 | ﹤0.01% | 631 |
|
2022
Q2 | $8K | Buy |
102
+12
| +13% | +$941 | ﹤0.01% | 568 |
|
2022
Q1 | $9K | Hold |
90
| – | – | ﹤0.01% | 580 |
|
2021
Q4 | $10K | Sell |
90
-5
| -5% | -$556 | ﹤0.01% | 585 |
|
2021
Q3 | $10K | Hold |
95
| – | – | ﹤0.01% | 576 |
|
2021
Q2 | $10K | Sell |
95
-1
| -1% | -$105 | ﹤0.01% | 577 |
|
2021
Q1 | $9K | Buy |
96
+30
| +45% | +$2.81K | ﹤0.01% | 583 |
|
2020
Q4 | $5K | Buy |
+66
| New | +$5K | ﹤0.01% | 706 |
|
2019
Q3 | – | Sell |
-211
| Closed | -$5K | – | 1064 |
|
2019
Q2 | $5K | Hold |
211
| – | – | ﹤0.01% | 610 |
|
2019
Q1 | $6K | Hold |
211
| – | – | ﹤0.01% | 557 |
|
2018
Q4 | $4K | Hold |
211
| – | – | ﹤0.01% | 631 |
|
2018
Q3 | $4 | Hold |
211
| – | – | ﹤0.01% | 650 |
|
2018
Q2 | $4 | Buy |
+211
| New | +$4 | ﹤0.01% | 715 |
|